711TiP A phase I/II, first-in-human, open-label, dose-escalation study of TAK-186, an EGFR × CD3ε COBRA T cell engager, in adult patients with unresectable, locally advanced, or metastatic solid tumors
| Autor: | Weickhardt, A.J. 1, Frentzas, S. 2, Lemech, C. 3, Srimani, J. 4, Yin, J. 5, Trepicchio, W.L. 6, Gorgun, C. 7, Kichenadasse, G. 8 |
|---|---|
| Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S492-S492 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|